Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001244969 | SCV001418226 | uncertain significance | Carnitine palmitoyl transferase 1A deficiency | 2021-08-28 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with leucine at codon 622 of the CPT1A protein (p.Pro622Leu). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs776782808, ExAC 0.03%). This variant has not been reported in the literature in individuals affected with CPT1A-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001244969 | SCV001466868 | uncertain significance | Carnitine palmitoyl transferase 1A deficiency | 2020-04-16 | no assertion criteria provided | clinical testing |